Tag: Greg Hunt

Australia Expected to Approve Pfizer for Children Under 12 by 2022

Australia is expected to approve Pfizer vaccines for children aged 5 to 11 by the end of 2021, according to Chief Medical Officer Paul Kelly. “The TGA has received their advice from Pfizer. In terms of an application for that age group, they are going through that process,” Kelly told the ABC on Tuesday. “That…


Flights From America and Singapore Will Be the First to Enter Australia

International commercial flights from North America and Singapore will be the first to carry passengers to Australia after the country lifts its international travel ban in November. Home Affairs Minister Karen Andrews confirmed that a Qantas flight from North America and a Singapore Airlines voyage would land in Sydney and that people would be able…


Medicare Australia Expands Rebate Schemes to Cover IVF Genetic Services, High Blood Pressure, and More

The federal government has expanded funding to allow more Australians to claim relevant Medicare rebates for IVF and genetics, high blood pressure, chronic bowel inflammation, and breast cancer treatment from Nov. 1. Health Minister Greg Hunt said that until now, people in their in vitro fertilisation (IVF) journey who know they carry genetic diseases could…


Aussie mRNA Vaccine Manufacturers to Be Decided This Week

Health Minister Greg Hunt says the federal government is in the advanced stages of determining which companies will manufacture mRNA vaccinations in Australia this week. Currently, Australia imports all mRNA vaccines such as Pfizer and Moderna. The only COVID-19 vaccine manufactured domestically is AstraZeneca, which is an adenovirus vaccine. Hunt did not speculate on the…


Australian Health Minister Confident Pfizer Will Be Approved for Children Aged 5 to 12

The Pfizer COVID-19 vaccine could soon be given double green light approval for use in Australian children aged 5 to 12. Federal Health Minister Greg Hunt said the drug regulatory body, the Therapeutic Goods Administration (TGA) had given Pfizer provisional determination, allowing the company to speed up their application. “I think their application is likely…


Australia Eyes COVID-19 Vaccination for Under-12s Despite Kids Having ‘Extremely Low’ Risks of COVID Hospitalisation

Australia is looking to commence its COVID-19 vaccinations for children as young as five amidst a debate on the pros and cons of vaccinating young kids, whose risk of developing severe symptoms from COVID-19 is “extremely low” according to studies. Health Minister Greg Hunt on Tuesday invited Pfizer to seek approval from Australia’s medical regulator…


Australia Eyes COVID-19 Vaccination for Under-12s Despite ‘Extremely Low’ Hospitalisation Risk

Australia is looking to commence its COVID-19 vaccinations for children as young as five amidst a debate on the pros and cons of vaccinating young kids, whose risk of developing severe symptoms from COVID-19 is “extremely low” according to studies. Health Minister Greg Hunt on Tuesday invited Pfizer to seek approval from Australia’s medical regulator…


Australian Employee Groups Welcome No Fault COVID-19 Indemnity Scheme

Employee and business groups have welcomed the federal government’s announcement on Saturday to introduce a no fault COVID-19 indemnity scheme that will give financial compensation to people who experience serious adverse side-effects from the vaccine. The scheme will give businesses the confidence to hand out vaccine mandates to employees by offering financial protection to all…


Staged Return to Classrooms Expected for NSW Students in Term 4

School students and parents across New South Wales will know more details about the return to school date by the end of this week, which may involve a staggered return strategy. Health and education officials met today to discuss the strategy to allow different year groups, starting from Kindergarten to Year 2 and Year 11…


New Nasal Spray Claims to Reduces CCP Virus Infectivity by Over 99 Percent in 30 Seconds: Scripps Research Institute

The developer of a nasal spray is claiming that its anti-viral nasal spray may significantly reduce the infectivity of respiratory and cold viruses, including the CCP (Chinese Communist Party) virus. The data published data on July 27, by the Australian-based company Starpharma claims that its research at the Scripps Research Institute in the United States into astodrimer sodium (SPL7013)…